Showing results (731-740 of 741) with videos related to

Sort By:
Pageof 75
Molecular Oncology|October 6, 2020
Optimized low-dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatmentMarloes Zoetemelk, George M Ramzy, Magdalena Rausch, et al.
Nature Immunology|December 22, 2005
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopesNicole Frahm, Photini Kiepiela, Sharon Adams, et al.
The Journal of Clinical Investigation|March 28, 2017
Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humansFederica Buonocore, Peter Kühnen, Jenifer P Suntharalingham, et al.
European Journal of Immunology|August 21, 2007
Extensive HLA class I allele promiscuity among viral CTL epitopesNicole Frahm, Karina Yusim, Todd J Suscovich, et al.
Science (New York, N.Y.)|August 3, 2023
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancersRuben Bill, Pratyaksha Wirapati, Marius Messemaker, et al.
Arthritis and Rheumatism|September 18, 2003
Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypesEbun Aganna, Linda Hammond, Philip N Hawkins, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 18, 2020
GATAD2B-associated neurodevelopmental disorder (GAND): clinical and molecular insights into a NuRD-related disorderChristine Shieh, Natasha Jones, Brigitte Vanle, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 13, 2020
Correction: GATAD2B-associated neurodevelopmental disorder (GAND): clinical and molecular insights into a NuRD-related disorderChristine Shieh, Natasha Jones, Brigitte Vanle, et al.
Journal of Medical Genetics|August 16, 2014
Genetic heterogeneity in Cornelia de Lange syndrome (CdLS) and CdLS-like phenotypes with observed and predicted levels of mosaicismMorad Ansari, Gemma Poke, Quentin Ferry, et al.
Pageof 75